Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. BioTissue Holdings Inc
FDA Inspection
•BioTissue Holdings Inc•February 6, 2018

BioTissue Holdings Inc – FDA Inspection, Feb 6, 2018

Record Details

This FDA Inspection record concerns BioTissue Holdings Inc, with an inspection on February 6, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
BioTissue Holdings Inc
Inspection Date
February 6, 2018
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
Person
  • Shavon L. Square (Company Rep)
View Company Profile

ID · adf9e664-a7c0-4ef7-a540-5973fcb81967

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1040962
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies
Outcome
Form 483 issued

FDA Citations

11
  1. 21 CFR 1271.195(b)Corrective actions
  2. 21 CFR 1271.190(d)(2)Documentation of activities
  3. 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
  4. 21 CFR 1271.195(c)Monitoring--cross contamination, exposure to CD
  5. 21 CFR 1271.200(a)Cleaned, sanitized per established schedules
  6. 21 CFR 1271.350(b)(2)Deviations not reported to FDA
  7. 21 CFR 1271.220(a)Causing contamination, increasing risks
  8. 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
  9. 21 CFR 1271.230(a)Validation & approval--established procedures
  10. 21 CFR 1271.220(c)Sampling representative (in-process HCT/Ps)

Showing 10 of 11 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of BioTissue Holdings Inc

10
DateClassificationOfficeProject area
September 1, 2026OAIFlorida District OfficeHuman Cellular, Tissue, and Gene Therapies
February 18, 2026VAIFlorida District OfficeCompliance: Medical Devices
March 6, 2024VAICenter for Devices and Radiological HealthPostmarket Assurance: Devices
August 15, 2019NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
July 16, 2019VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
View all 10 other inspections on the company page
Other documents for BioTissue Holdings Inc
  • FDA Inspection 1312222 - 2026-09-01
  • FDA Inspection 1304322 - 2026-02-18
  • FDA Inspection 1230477 - 2024-03-06
  • FDA Inspection 1101487 - 2019-08-15
  • FDA Inspection 1096403 - 2019-07-16

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore BioTissue Holdings Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.